We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 15.72% |
| 3 | Consumer Discretionary | 12.22% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
ArcelorMittal
MT
$48B
| $9.68M | 0.02% |
679,400
+191,500
| +39% | +$2.94M |
2018 Q2
5 quarters
|
|
452
Healthpeak Properties
DOC
$13.2B
| $9.66M | 0.02% |
271,222
-25,827
| -9% | -$872K |
2017 Q3
8 quarters
|
|
453
Ameren
AEE
$29.3B
| $9.55M | 0.02% |
119,318
-1,710
| -1% | -$131K |
2017 Q3
8 quarters
|
|
454
Darden Restaurants
DRI
$24.6B
| $9.52M | 0.02% |
80,525
-75,139
| -48% | -$9.17M |
2017 Q3
8 quarters
|
|
455
Microchip Technology
MCHP
$41.2B
| $9.47M | 0.02% |
203,762
-2,286
| -1% | -$104K |
2017 Q3
8 quarters
|
|
456
Ultrapar
UGP
$8.25B
| $9.41M | 0.02% |
2,106,200
-488,102
| -19% | -$2.3M |
2017 Q3
8 quarters
|
|
457
DELISTED
Kellanova
K
| $9.29M | 0.02% |
153,567
-3,875
| -2% | -$221K |
2017 Q3
8 quarters
|
|
458
Regeneron Pharmaceuticals
REGN
$82B
| $9.28M | 0.02% |
33,462
-5,497
| -14% | -$1.63M |
2017 Q3
8 quarters
|
|
459
DELISTED
Pioneer Natural Resource Co.
PXD
| $9.23M | 0.02% |
73,384
-1,201
| -2% | -$159K |
2017 Q3
8 quarters
|
|
460
Idexx Laboratories
IDXX
$44.3B
| $9.12M | 0.02% |
33,545
-371
| -1% | -$103K |
2017 Q3
8 quarters
|
|
461
Northern Trust
NTRS
$30.5B
| $9.12M | 0.02% |
97,759
-2,322
| -2% | -$213K |
2017 Q3
8 quarters
|
|
462
Citizens Financial Group
CFG
$26.9B
| $9.09M | 0.02% |
256,977
-401,340
| -61% | -$14M |
2017 Q3
8 quarters
|
|
463
Centene
CNC
$34.5B
| $9.08M | 0.02% |
209,931
-31,616
| -13% | -$1.54M |
2017 Q3
8 quarters
|
|
464
Principal Financial Group
PFG
$23.5B
| $9.01M | 0.02% |
157,609
-3,088
| -2% | -$174K |
2017 Q3
8 quarters
|
|
465
Jones Lang LaSalle
JLL
$14.3B
| $8.95M | 0.02% |
64,364
-94,908
| -60% | -$13.1M |
2017 Q3
8 quarters
|
|
466
Vistra
VST
$51.7B
| $8.93M | 0.02% |
334,130
-261,143
| -44% | -$6.21M |
2018 Q1
6 quarters
|
|
467
Blackstone Mortgage Trust
BXMT
$1.82B
| $8.93M | 0.02% |
248,984
+60,000
| +32% | +$2.13M |
2018 Q4
3 quarters
|
|
468
Brixmor Property Group
BRX
$8.54B
| $8.91M | 0.02% |
438,991
-333
| -0.1% | -$6.26K |
2017 Q3
8 quarters
|
|
469
Cintas
CTAS
$84.8B
| $8.9M | 0.02% |
132,740
-33,348
| -20% | -$2.13M |
2017 Q3
8 quarters
|
|
470
Lumen Technologies, Inc. Common Stock
LUMN
$4.83B
| $8.87M | 0.02% |
710,214
-17,104
| -2% | -$203K |
2017 Q3
8 quarters
|
|
471
Clorox
CLX
$10.5B
| $8.75M | 0.02% |
57,599
-2,808
| -5% | -$444K |
2017 Q3
8 quarters
|
|
472
Fortive
FTV
$17.5B
| $8.67M | 0.02% |
200,541
-238,413
| -54% | -$11M |
2017 Q3
8 quarters
|
|
473
Nebius Group N.V.
NBIS
$47B
| $8.66M | 0.02% |
247,388
+1,995
| +0.8% | +$75.3K |
2017 Q3
8 quarters
|
|
474
Rockwell Automation
ROK
$47.6B
| $8.63M | 0.02% |
52,396
-2,698
| -5% | -$426K |
2017 Q3
8 quarters
|
|
475
Carnival Corporation Ltd
CCL
$36.1B
| $8.62M | 0.02% |
197,107
-3,646
| -2% | -$168K |
2017 Q3
8 quarters
|
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.